FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Brunner

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Peter Matzneller; Raffaella Tacchi; Ottavia Annoni; Martin Brunner; Angela Burian; Vittoria Lauro; Wolfgang Martin; Markus Zeitlinger
A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
Robert Sauermann; Wolfgang M Schmidt; Martin Brunner; Michael Krebs; Markus Müller
Ramipril modulates circadian gene expression in skeletal muscle.
Claudia C Wagner; Enrico Frimonti; Kurt Kletter; Antonio Longo; Markus Müller; Silvia Pace; Massimo Pedrani; Antonio Rusca; M Tschurlovits; Roberto Villa; Martin Brunner
Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Brunner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peter Matzneller; Raffaella Tacchi; Ottavia Annoni; Martin Brunner; Angela Burian; Vittoria Lauro; Wolfgang Martin; Markus Zeitlinger
A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
Pharmacology 2012;89(3-4):188-91.
2011: Robert Sauermann; Wolfgang M Schmidt; Martin Brunner; Michael Krebs; Markus Müller
Ramipril modulates circadian gene expression in skeletal muscle.
Pharmacogenetics and genomics 2011;21(11):751-9.
2011: Claudia C Wagner; Enrico Frimonti; Kurt Kletter; Antonio Longo; Markus Müller; Silvia Pace; Massimo Pedrani; Antonio Rusca; M Tschurlovits; Roberto Villa; Martin Brunner
Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation.
Xenobiotica; the fate of foreign compounds in biological systems 2011;41(11):988-95.
2011: Martin Brunner; David Davies; Wolfgang Martin; Chiara Leuratti; Edith Lackner; Markus Müller
A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects.
British journal of clinical pharmacology 2011;71(6):852-9.
2010: Stefan Aschauer; Friedrich Mittermayer; Claudia C Wagner; Wolfgang M Schmidt; Martin Brunner; Helmuth Haslacher; Michael Wolzt; Markus Müller
Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism.
European journal of clinical investigation 2010;40(8):700-5.
2010: Martin Bauer; H Bliesath; C Leuratti; E Lackner; W Dieterle; Markus Müller; Martin Brunner
Disposition and metabolism of ralfinamide, a novel Na-channel blocker, in healthy male volunteers.
Pharmacology 2010;86(5-6):297-305.
2010: Martin Brunner; Boban M Erovic; G Heiduschka; Stéphane Schneider; Johannes Pammer; S Frantal; Dietmar Thurnher
RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes 2010;44(3-4):214-9.
2007: Oliver Langer; Martin Bauer; Alexander Hammers; Rudolf Karch; Ekaterina Pataraia; Matthias Koepp; Aiman Abrahim; Gert Luurtsema; Martin Brunner; Raute Sunder-Plassmann; Fritz Zimprich; Christian Joukhadar; Stephan Gentzsch; Robert Dudczak; Kurt Kletter; Markus Müller; Christoph Baumgartner
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil.
Epilepsia 2007;48(9):1774-84.
2006: Martin Bauer; Oliver Langer; Peter Dal-Bianco; Rudolf Karch; Martin Brunner; Aiman Abrahim; Rupert Lanzenberger; Andrea Hofmann; Christian Joukhadar; Paolo Carminati; Orlando Ghirardi; Paola Piovesan; Gianluigi Forloni; Mario E Corrado; Nadège Lods; Robert Dudczak; Eduard Auff; Kurt Kletter; Markus Müller
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
Clinical pharmacology and therapeutics 2006;80(3):216-27.
2006: Martin Brunner; Oliver Langer
Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution.
The AAPS journal 2006;8(2):E263-71.
2006: Martin Brunner; Edith Lackner; P S Exler; H C Fluiter; Kurt Kletter; M Tschurlovits; Robert Dudczak; Hans-Georg Eichler; Markus Müller
5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.
Alimentary pharmacology & therapeutics 2006;23(1):137-44.
2006: Martin Brunner; S Ziegler; A F D Di Stefano; Pejman Dehghanyar; Kurt Kletter; M Tschurlovits; R Villa; Roberta Bozzella; Giuseppe Celasco; L Moro; A Rusca; Robert Dudczak; Markus Müller
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation.
British journal of clinical pharmacology 2006;61(1):31-8.
2005: Oliver Langer; Rudolf Karch; Ulrich Müller; Georg Dobrozemsky; Aiman Abrahim; Markus Zeitlinger; Edith Lackner; Christian Joukhadar; Robert Dudczak; Kurt Kletter; Markus Müller; Martin Brunner
Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1835-41.
2005: Martin Brunner; Pejman Dehghanyar; Bernd Seigfried; Wolfgang Martin; Georg Menke; Markus Müller
Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.
British journal of clinical pharmacology 2005;60(5):573-7.
2005: Sophie Ziegler; Karam Kostner; Christiane Thallinger; Andreas Bur; Martin Brunner; Michael Wolzt; Christian Joukhadar
Wine ingestion has no effect on lipid peroxidation products.
Pharmacology 2005;75(3):152-6.
2005: Martin Brunner; Hartmut Derendorf; Markus Müller
Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs.
Current opinion in pharmacology 2005;5(5):495-9.
2005: Martin Brunner; Harald Vogelsang; R Greinwald; Kurt Kletter; H Kvaternik; Claudia Schrolnberger; Hans-Georg Eichler; H Brunner; Robert Dudczak; Markus Müller
Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis.
Alimentary pharmacology & therapeutics 2005;22(5):463-70.
2005: Martin Brunner; Oliver Langer; Raute Sunder-Plassmann; Georg Dobrozemsky; Ulrich Müller; Wolfgang Wadsak; Andreas Krcal; Rudolf Karch; Christine Mannhalter; Robert Dudczak; Kurt Kletter; Ilka Steiner; Christoph Baumgartner; Markus Müller
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans.
Clinical pharmacology and therapeutics 2005;78(2):182-90.
2005: Sophie Ziegler; Martin Schillinger; Marion Funk; Katharina Felber; Markus Exner; Wolfgang Mlekusch; shahram sabeti; Jasmin Amighi; Erich Minar; Martin Brunner; Markus Müller; Christine Mannhalter
Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease.
Stroke; a journal of cerebral circulation 2005;36(7):1394-9.
2005: Andreas Bur; Christian Joukhadar; N Klein; Goran Mitulovic; Rainer Schmid; Ernst Agneter; Markus Müller; Martin Brunner
Effect of exercise on transdermal nicotine release in healthy habitual smokers.
International journal of clinical pharmacology and therapeutics 2005;43(5):239-43.
2005: Eva Münster; Sophie Ziegler; Martin Brunner
[Therapeutic implications of polymorphisms in cytochromes and drug transporters].
Wiener medizinische Wochenschrift (1946) 2005;155(3-4):54-8.
2005: Oliver Langer; Martin Brunner; Markus Zeitlinger; Sophie Ziegler; Ulrich Müller; Georg Dobrozemsky; Edith Lackner; Christian Joukhadar; Markus Mitterhauser; Wolfgang Wadsak; Erich Minar; Robert Dudczak; Kurt Kletter; Markus Müller
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
European journal of nuclear medicine and molecular imaging 2005;32(2):143-50.
2005: Sophie Ziegler; Elisabeth Alt; Martin Brunner; Wolfgang Speiser; Erich Minar
Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100.
Seminars in thrombosis and hemostasis 2005;31(4):416-9.
2005: Raute Sunder-Plassmann; Sandra Rieger; Georg Endler; Martin Brunner; Markus Müller; Christine Mannhalter
Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(2):192-4.
2004: Florian Islinger; Rene Bouw; Mathias Stahl; Edith Lackner; Petra Zeleny; Martin Brunner; Markus Müller; Hans-Georg Eichler; Christian Joukhadar
Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose.
Antimicrobial agents and chemotherapy 2004;48(11):4246-9.
2004: Martin Brunner; Oliver Langer; Georg Dobrozemsky; Ulrich Müller; Markus Zeitlinger; Markus Mitterhauser; Wolfgang Wadsak; Robert Dudczak; Kurt Kletter; Markus Müller
[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.
Antimicrobial agents and chemotherapy 2004;48(10):3850-7.
2004: Pejman Dehghanyar; Bernhard X Mayer; Khodadad Namiranian; Hermann Mascher; Markus Müller; Martin Brunner
Topical skin penetration of diclofenac after single- and multiple-dose application.
International journal of clinical pharmacology and therapeutics 2004;42(7):353-9.
2004: Sophie Ziegler; Elisabeth Alt; Martin Brunner; Wolfgang Speiser; Erich Minar
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients.
Annals of hematology 2004;83(2):92-4.
2003: Robert Sauermann; Markus Zeitlinger; Boban M Erovic; Claudia Marsik; Apostolos Georgopoulos; Markus Müller; Martin Brunner; Christian Joukhadar
Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model.
International journal of antimicrobial agents 2003;22(6):574-8.
2003: Martin Brunner; R Greinwald; Kurt Kletter; H Kvaternik; Mario E Corrado; Hans-Georg Eichler; Markus Müller
Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers.
Alimentary pharmacology & therapeutics 2003;17(9):1163-9.
2003: Oliver Langer; Markus Mitterhauser; Martin Brunner; Markus Zeitlinger; Wolfgang Wadsak; Bernhard X Mayer; Kurt Kletter; Markus Müller
Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans.
Nuclear medicine and biology 2003;30(3):285-91.
2003: Martin Brunner; R Assandri; Kurt Kletter; M Tschurlovits; Mario E Corrado; R Villa; Hans-Georg Eichler; Markus Müller
Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.
Alimentary pharmacology & therapeutics 2003;17(3):395-402.
2002: Robert M Mader; Claudia Schrolnberger; Blanka Rizovski; Martin Brunner; Catharina Wenzel; G Locker; Hans-Georg Eichler; M Mueller; Guenther G Steger
Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.
International journal of clinical pharmacology and therapeutics 2002;40(12):571-2.
2002: Martin Brunner; Heino Stabeta; Jan-Georg Möller; Claudia Schrolnberger; Boban M Erovic; Ursula Hollenstein; Markus Zeitlinger; Hans-Georg Eichler; Markus Müller
Target site concentrations of ciprofloxacin after single intravenous and oral doses.
Antimicrobial agents and chemotherapy 2002;46(12):3724-30.
2002: Martin Brunner; Markus Müller
Microdialysis: an in vivo approach for measuring drug delivery in oncology.
European journal of clinical pharmacology 2002;58(4):227-34.
2001: C Schrolnberger; Martin Brunner; B X Mayer; H G Eichler; Markus Müller
Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studies.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):297-306.
2001: Christian Joukhadar; Martin Frossard; Bernhard X Mayer; Martin Brunner; Nikolas Klein; Peter Siostrzonek; Hans-Georg Eichler; Markus Müller
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.
Critical care medicine 2001;29(2):385-91.
2000: S Delacher; Hartmut Derendorf; Ursula Hollenstein; Martin Brunner; Christian Joukhadar; S Hofmann; Apostolos Georgopoulos; Hans-Georg Eichler; Markus Müller
A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans.
The Journal of antimicrobial chemotherapy 2000;46(5):733-9.
2000: Martin Brunner; Christian Joukhadar; R Schmid; Boban M Erovic; Hans-Georg Eichler; Markus Müller
Validation of urea as an endogenous reference compound for the in vivo calibration of microdialysis probes.
Life sciences 2000;67(8):977-84.
2000: Martin Brunner; Thomas Pernerstorfer; Bernhard X Mayer; Hans-Georg Eichler; Markus Müller
Surgery and intensive care procedures affect the target site distribution of piperacillin.
Critical care medicine 2000;28(6):1754-9.
2000: Bernhard X Mayer; Ursula Hollenstein; Martin Brunner; Hans-Georg Eichler; Markus Müller
Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers.
Electrophoresis 2000;21(8):1558-64.
2000: Ursula Hollenstein; Martin Brunner; Bernhard X Mayer; S Delacher; Boban M Erovic; Hans-Georg Eichler; Markus Müller
Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers.
Clinical pharmacology and therapeutics 2000;67(3):229-36.
1999: Markus Müller; Heino Stass; Martin Brunner; JG Möller; Edith Lackner; Hans-Georg Eichler
Penetration of moxifloxacin into peripheral compartments in humans.
Antimicrobial agents and chemotherapy 1999;43(10):2345-9.
1999: Markus Müller; Martin Brunner; Ursula Hollenstein; Christian Joukhadar; R Schmid; Erich Minar; Herbert Ehringer; Hans-Georg Eichler
Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
Antimicrobial agents and chemotherapy 1999;43(8):2056-8.
1999: Martin Brunner; Ursula Hollenstein; S Delacher; D Jäger; R Schmid; Edith Lackner; Apostolos Georgopoulos; Hans-Georg Eichler; Markus Müller
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.
Antimicrobial agents and chemotherapy 1999;43(5):1307-9.
1998: Robert M Mader; Martin Brunner; Blanka Rizovski; C Mensik; Guenther G Steger; Hans-Georg Eichler; Markus Müller
Analysis of microdialysates from cancer patients by capillary electrophoresis.
Electrophoresis 1998;19(16-17):2981-5.
1998: Martin Brunner; A Schmiedberger; R Schmid; D Jäger; E Piegler; Hans-Georg Eichler; Markus Müller
Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.
British journal of clinical pharmacology 1998;46(5):425-31.
1998: Markus Müller; Martin Brunner; R Schmid; E M Putz; A Schmiedberger; I Wallner; Hans-Georg Eichler
Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans.
Life sciences 1998;62(15):PL227-34.
1997: Markus Müller; Hermann Mascher; Ch Kikuta; S Schäfer; Martin Brunner; Guido T Dorner; Hans-Georg Eichler
Diclofenac concentrations in defined tissue layers after topical administration.
Clinical pharmacology and therapeutics 1997;62(3):293-9.
1997: Markus Müller; T Burgdorff; B Jansen; Ernst A Singer; Ernst Agneter; Guido T Dorner; Martin Brunner; Hans-Georg Eichler
In vivo drug-response measurements in target tissues by microdialysis.
Clinical pharmacology and therapeutics 1997;62(2):165-70.